Business · Companies · 1 hr ago
Transasia Bio-Medicals considers selling up to 20% stake to raise $200 million
Transasia Bio-Medicals is considering selling up to 20% of the company to raise $150 million to $200 million.
The Mumbai-based company makes medical equipment and diagnostic products, including tests for blood and other samples.
Several private equity firms have expressed interest, including TPG, Warburg Pincus, ChrysCapital, Motilal Oswal and Quadria Capital.
The talks are at an early stage, and the exact terms have not been decided.
The fundraising could combine new shares and existing shares, with O3 Capital helping arrange the deal.
Founded in 1979, Transasia grew from distributing imported equipment into a manufacturer and is part of the Erba group, which operates in 150 countries.
The proposed sale would be its first external capital raise, as India’s medtech market is projected to grow from $12 billion in FY24 to $50 billion by 2030.
Transasia Bio-Medicals is exploring the sale of up to a 20% stake to raise $150 million to $200 million.
Several large private equity funds have expressed interest, but discussions are at an early stage.
The fundraising would be the medical equipment maker’s first external capital raise.
The proposed round may combine primary and secondary share sales, with the structure still subject to change.
O3 Capital is helping the company with the fundraising.
- Who
- Transasia Bio-Medicals is considering the stake sale, with several private equity funds expressing interest.
- What
- The company is exploring a sale of up to 20% to raise $150 million to $200 million.
- When
- The discussions were at an early stage when reported on 16 November 2026.
- Where
- Transasia is based in Mumbai, India.
- Why
- The company is seeking to raise capital through its first external fundraising.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Potential stake sale
- Up to 20%
- Fundraising target
- $150 million to $200 million
- Interested funds
- TPG, Warburg Pincus, ChrysCapital, Motilal Oswal and Quadria Capital
- Fundraising adviser
- O3 Capital
- Company base
- Mumbai, India
What people are saying
The round is likely a mix of primary and secondary share sale although the exact structures are subject to change depending on the incoming investor. O3 Capital is helping the company with the fundraise.